Welcome to LookChem.com Sign In|Join Free
  • or
5,6,7,8-tetrahydro-5-oxonaphthalene-1-carbonitrile is a chemical compound with the molecular formula C13H9NO. It is a naphthalene derivative that contains a nitrile functional group. 5,6,7,8-tetrahydro-5-oxonaphthalene-1-carbonitrile is characterized by its unique structure and reactivity, making it a valuable intermediate in various chemical processes.

138764-20-2

Post Buying Request

138764-20-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

138764-20-2 Usage

Uses

Used in Organic Synthesis:
5,6,7,8-tetrahydro-5-oxonaphthalene-1-carbonitrile is used as a building block in organic synthesis for the creation of various chemical compounds. Its distinct structure and functional groups allow for versatile reactions and the formation of a wide range of products.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 5,6,7,8-tetrahydro-5-oxonaphthalene-1-carbonitrile is utilized as a key intermediate for the synthesis of pharmacologically active compounds. Its properties contribute to the development of new drugs with potential therapeutic applications.
Used in Pharmaceutical Production:
5,6,7,8-tetrahydro-5-oxonaphthalene-1-carbonitrile is used as a crucial component in the production of pharmaceuticals. Its presence in the molecular structure of certain drugs enhances their efficacy and contributes to their therapeutic effects.
Used in Agrochemical Development:
5,6,7,8-tetrahydro-5-oxonaphthalene-1-carbonitrile also finds application in the development of agrochemicals, where it serves as a building block for the synthesis of compounds with pesticidal or herbicidal properties, contributing to increased crop yields and protection against pests.
Used in Material Science:
5,6,7,8-tetrahydro-5-oxonaphthalene-1-carbonitrile has potential applications in material science, particularly in the development of new materials with unique properties. Its structural features make it a promising candidate for research and innovation in this field.
Used in Dye Development:
In the dye industry, 5,6,7,8-tetrahydro-5-oxonaphthalene-1-carbonitrile is used for the development of new dyes with specific color characteristics and properties. Its chemical structure allows for the creation of dyes with improved stability and application versatility.
Overall, 5,6,7,8-tetrahydro-5-oxonaphthalene-1-carbonitrile is a versatile chemical compound with a wide range of applications across various industries, including organic synthesis, medicinal chemistry, pharmaceuticals, agrochemicals, material science, and dye development. Its unique structure and reactivity make it an important target for research and innovation.

Check Digit Verification of cas no

The CAS Registry Mumber 138764-20-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,8,7,6 and 4 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 138764-20:
(8*1)+(7*3)+(6*8)+(5*7)+(4*6)+(3*4)+(2*2)+(1*0)=152
152 % 10 = 2
So 138764-20-2 is a valid CAS Registry Number.

138764-20-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-oxo-7,8-dihydro-6H-naphthalene-1-carbonitrile

1.2 Other means of identification

Product number -
Other names 5-cyano-1-tetralone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:138764-20-2 SDS

138764-20-2Relevant academic research and scientific papers

Seco-B-ring steroidal dienynes with aromatic D ring: Design, synthesis and biological evaluation

Szybinski, Marcin,Brzeminski, Pawel,Fabisiak, Adrian,Berkowska, Klaudia,Marcinkowska, Ewa,Sicinski, Rafal R.

, (2017)

Continuing our structure-activity studies on the vitamin D analogs with the altered intercyclic seco-B-ring fragment, we designed compounds possessing dienyne system conjugated with the benzene D ring. Analysis of the literature data and the docking exper

4H-THIENO[3,2-C]CHROMENE-BASED INHIBITORS OF NOTUM PECTINACETYLESTERASE AND METHODS OF THEIR USE

-

Page/Page column 17, (2012/12/13)

Compounds that may be used to inhibit Notum Pectinacetylesterase are described, as well as compositions comprising them, and methods of their use to treat diseases and disorders affecting bone.

SPHINGOSINE 1 PHOSPHATE RECEPTOR MODULATORS AND METHODS OF CHIRAL SYNTHESIS

-

Page/Page column 54-55, (2011/06/16)

Compounds that selectively modulate the sphingosine 1 phosphate receptor are provided including compounds which modulate subtype 1 of the S1P receptor. Methods of chiral synthesis of such compounds is provided. Uses, methods of treatment or prevention and methods of preparing inventive compositions including inventive compounds are provided in connection with the treatment or prevention of diseases, malconditions, and disorders for which modulation of the sphingosine 1 phosphate receptor is medically indicated.

Benzo[A] [phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase I and II

-

, (2008/06/13)

A compound which is a benzo[a]phenazine-11-carboxamide derivative of formula (I) wherein each of R1 to R4, which are the same or different, is selected from hydrogen, halogen, hydroxyl, C1-C6 alkoxy which is unsubstituted or substituted, heteroaryloxy, C1-C6 alkyl which is unsubstituted or substituted, nitro, cyano, azido, amidoxime, CO2R10, CON(R12)2, OCON(R12), SR10, SOR11, SO2(R11), SO2N(R12)2, N(R12)2, NR10SO2R11, N(SO2R11)2NR10(CH2)nCN, NR10COR11, OCOR11 or COR10; each of R5 to R7, which are the same or different, is selected from hydrogen, halogen, hydroxy, C1-C6 alkoxy, C1-C6 alkyl, SR10 and N(R12)2; Q is C1-C6 alkylene which is unsubstituted or substituted by (i) C1-C6 alkyl which is unsubstituted or substituted, (ii) hydroxy, provided that the hydroxy group is not, to either of the N atoms adjacent to Q in formula (I), (iii) CO2R10, or (iv) CON(R12); R1 and R9, which are the same or different, are each hydrogen or C1-C6 alkyl, or R8 and R9 together with the nitrogen atom to which they are attached form a saturated 5- or 6-membered N-containing heterocyclic ring which may include one additional heteroatom selected from O, N and S, or one of R8 and R9 is an alkylene chain optionally interrupted by O, N or S, which is attached to a carbon atom on the alkylene chain represented by Q to complete a saturated 5- or 6-membered N-containing heterocyclic ring as defined above; or a pharmaceutically acceptable salt thereof; with the proviso that at least one R1 to R4 is other than hydrogen. These compounds are inhibitors of topoisomerase I and/or topoisomerase II and can be used to treat tumours, including tumours which express MDR.

Novel angular benzophenazines: Dual topoisomerase I and topoisomerase II inhibitors as potential anticancer agents

Vicker, Nigel,Burgess, Luke,Chuckowree, Irina S.,Dodd, Rory,Folkes, Adrian J.,Hardick, David J.,Hancox, Timothy C.,Miller, Warren,Milton, John,Sohal, Sukhjit,Wang, Shouming,Wren, Stephen P.,Charlton, Peter A.,Dangerfield, Wendy,Liddle, Chris,Mistry, Prakash,Stewart, Alistair J.,Denny, William A.

, p. 721 - 739 (2007/10/03)

A series of substituted angular benzophenazines were prepared using a new synthetic route via a novel regiocontrolled condensation of 1,2-naphthoquinones and 2,3-diaminobenzoic acids. The synthesis and biological activity of this new series of substituted

Imidazole derivatives, their preparation and their use as S-adenosylmethionine decarboxylase (=SAMDC) inhibitors

-

, (2008/06/13)

Described are compounds of formula I STR1 wherein R1 is hydrogen or hydroxy; R2, R2 ' and R2 " are each independently of the others hydrogen or a substituent other than hydrogen; either R3 is hydrogen or a substituent other than hydrogen and R4 is hydrogen or lower alkyl, or R3 and R4 together form a divalent radical of the formula --(CH2)n -- wherein n is 2 or 3; R5 and R6 are each independently of the other hydrogen, alkyl or aryl; and either R7 and R8 are each hydrogen, or R7 and R8 together form a bond; tautomers thereof, provided that at least one tautomerisable group is present; and salts thereof. The compounds inhibit the enzyme S-adenosylmethionine decarboxylase and are suitable, for example, for the treatment of tumours and protozoal infections.

Aminodienylesters. I: The cycloaddition reactions of tert- aminodienylester with α,β-unsaturated carbonyl compounds, styrenes, and quinones

Koike, Takeshi,Tanabe, Mituharu,Takeuchi, Naoki,Tobinaga, Seisho

, p. 243 - 248 (2007/10/03)

Methyl 5-(N,N-dimethylamino)-2,4-pentadienoate (tert-aminodienylester 1) was synthesized by condensation of methyl crotonate (2) with N,N,N',N'- tetramethylenediamine (3). The reactivity of 1 was investigated with methyl propiolate (4), dimethyl 2-butynedionate (5), dimethyl maleate (6), dimethyl fumarate (7), 2-buten-4-olide (8), 2-cyclohexenone (9), styrene (10), trans- β-nitrostyrene (11), 1,4-benzoquinone (19), methyl 1,4-naphthoquinone-5- carboxylate (21), 1,4-naphthoquinone (24), juglone (26), 5-methoxy-1,4- naphthoquinone (28), naphthazarin (31), and naphthazarin dimethyl ether (33). In addition, 5-(N,N-dimethylamino)-2,4-pentadienenitrile (tert-aminodienyl- nitrile 37) was synthesized by condensation of crotononitrile (36) with 3. The reactivity of 37 was investigated with dimethyl 2-butynedionate (5), and 2-cyclohexenone (9).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 138764-20-2